PRCX Stock Performance, Insider Transaction and News

PRCX - PHOENIX RISING COS

Market Cap	104.99K	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-8.64M	Forward P/E	-	EPS next Y	-	50D Avg Chg	-39.00%
Sales	17.27M	PEG	-	EPS past 5Y	-	200D Avg Chg	-72.00%
Dividend	N/A	Price/Book	N/A	EPS next 5Y	-	52W High Chg	-99.00%
Recommedations	-	Quick Ratio	0.28	Shares Outstanding	1.05B	52W Low Chg	100.00%
Insider Own	6.83%	ROA	-2.06%	Shares Float	1.01B	Beta	-0.80
Inst Own	-	ROE	-	Shares Shorted/Prior	-/-	Price	0.00010
Gross Margin	1.44%	Profit Margin	-50.02%	Avg. Volume	6,484,816	Target Price	-
Oper. Margin	-5.59%	Earnings Date	-	Volume	1,000,000	Change	0.00%

Financial Services | Asset Management | United States

About PHOENIX RISING COS

Phoenix Rising Companies, through its subsidiaries, engages in trading in oil, gas, and lubricant products in the People's Republic of China. The company was formerly known as Resort Savers, Inc. and changed its name to Phoenix Rising Companies in May 2020. Phoenix Rising Companies was founded in 2012 and is based in Cedartown, Georgia.

PRCX Chatroom

RichieRich1018 Posted - 2 months ago

$PRCX

RichieRich1018 Posted - 3 months ago

$PRCX

RichieRich1018 Posted - 3 months ago

@BMC001 $PRCX That would be great!!! Patiently waiting!

BMC001 Posted - 3 months ago

$PRCX Are we coming back to life?

RichieRich1018 Posted - 3 months ago

$PRCX

RichieRich1018 Posted - 3 months ago

$PRCX I’m looking forward to the day!!! https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174860643

RichieRich1018 Posted - 07/26/24

$PRCX

RichieRich1018 Posted - 07/26/24

@Thegreatbobo $PRCX - That's a very good Question!

RichieRich1018 Posted - 07/25/24

$PRCX $PRCX it's time for the Phoenix to Rise!!! Almost 1 year since we've heard anything!

RichieRich1018 Posted - 07/24/24

$PRCX

Irishihadmore Posted - 4 months ago

$PRCX

Thegreatbobo Posted - 4 months ago

$PRCX whats up with this Gem?

DonCorleone77 Posted - 4 months ago

$PRCX Pacira should be bought on today's selloff, says H.C. Wainwright H.C. Wainwright analyst Oren Livnat recommeds buying Pacira BioSciences on weakness after the FDA confirmed it approved the first-ever generic Exparel. The selloff is not surprising given the Pacira story is almost entirely levered to Exparel, and this generic approval "undermines a core belief of some PCRX investors" that a generic was impossible to get approved, the analyst tells investors in a research note. The firm's bullish view on the stock is based on seeing a good probability that Pacira ultimately settles with the challenger and/or wins litigation this year, resulting in "meaningful multiple expansion in either case." It reiterates a Buy rating on the shares with a $57 price target. The stock in midday trading is down 25% to $21.31.

RichieRich1018 Posted - 4 months ago

$PRCX

RichieRich1018 Posted - 4 months ago

$PRCX

RichieRich1018 Posted - 4 months ago

$PRCX

RichieRich1018 Posted - 4 months ago

@Irishihadmore $PRCX THAT IS! Trade up to .0001. This morning.???

Irishihadmore Posted - 4 months ago

$PRCX

RichieRich1018 Posted - 6 months ago

$GME $PRCX